<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(8)</volume><submitter>Manamela NP</submitter><pubmed_abstract>In addition to neutralization, Fc effector function contributes to vaccine-mediated protection against severe SARS-CoV-2 infection. However, differential coordination and cross-reactivity of Fc effector functions across vaccines is not clearly defined. A secondary analysis of three vaccines with BNT162b2, Ad26.CoV2.S (NCT04838795), and ChAdOx1 nCoV-19 (NCT04444674) reveals that BNT162b2 elicits the highest levels of binding, neutralization, and Fc effector function with antibody-dependent cellular cytotoxicity (ADCC), phagocytosis (ADCP), and complement deposition (ADCD) significantly differing by vaccine modality. Ad26.CoV2.S showed low ADCD activity before a homologous boost, which significantly increased this function. BNT162b2 vaccination triggered higher levels of cross-reactive neutr</pubmed_abstract><journal>iScience</journal><pagination>113084</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12309960</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SARS-CoV-2 vaccines elicit differential Fc effector functions.</pubmed_title><pmcid>PMC12309960</pmcid><pubmed_authors>Mzindle N</pubmed_authors><pubmed_authors>Hermanus T</pubmed_authors><pubmed_authors>Ayres F</pubmed_authors><pubmed_authors>Gray GG</pubmed_authors><pubmed_authors>Richardson SI</pubmed_authors><pubmed_authors>Motsoeneng BM</pubmed_authors><pubmed_authors>Moore PL</pubmed_authors><pubmed_authors>Spencer H</pubmed_authors><pubmed_authors>Makhado Z</pubmed_authors><pubmed_authors>Serage R</pubmed_authors><pubmed_authors>Manamela NP</pubmed_authors><pubmed_authors>Madhi SA</pubmed_authors><pubmed_authors>Bekker LG</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 vaccines elicit differential Fc effector functions.</name><description>In addition to neutralization, Fc effector function contributes to vaccine-mediated protection against severe SARS-CoV-2 infection. However, differential coordination and cross-reactivity of Fc effector functions across vaccines is not clearly defined. A secondary analysis of three vaccines with BNT162b2, Ad26.CoV2.S (NCT04838795), and ChAdOx1 nCoV-19 (NCT04444674) reveals that BNT162b2 elicits the highest levels of binding, neutralization, and Fc effector function with antibody-dependent cellular cytotoxicity (ADCC), phagocytosis (ADCP), and complement deposition (ADCD) significantly differing by vaccine modality. Ad26.CoV2.S showed low ADCD activity before a homologous boost, which significantly increased this function. BNT162b2 vaccination triggered higher levels of cross-reactive neutr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-03-16T05:52:20.535Z</modification><creation>2025-08-14T03:06:18.836Z</creation></dates><accession>S-EPMC12309960</accession><cross_references><pubmed>40740485</pubmed><doi>10.1016/j.isci.2025.113084</doi></cross_references></HashMap>